These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 30117787

  • 1. Discrepant Clinical Significance of CD28+CD8- and CD4+CD25high Regulatory T Cells During the Progression of Hepatitis B Virus Infection.
    Shen XH, Xu P, Yu X, Song HF, Chen H, Zhang XG, Wu MY, Wang XF.
    Viral Immunol; 2018 Oct; 31(8):548-558. PubMed ID: 30117787
    [Abstract] [Full Text] [Related]

  • 2. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.
    Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, Zhao JM, Zhang B, Shi M, Ding X, Tang Z, Fu YX, Wang FS.
    J Immunol; 2006 Jul 01; 177(1):739-47. PubMed ID: 16785573
    [Abstract] [Full Text] [Related]

  • 3. IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.
    Zhou Y, Zhang H, Li Y.
    Cytokine; 2015 May 01; 73(1):169-75. PubMed ID: 25752977
    [Abstract] [Full Text] [Related]

  • 4. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.
    Ma L, Cai YJ, Yu L, Feng JY, Wang J, Li C, Niu JQ, Jiang YF.
    Antimicrob Agents Chemother; 2013 Mar 01; 57(3):1304-11. PubMed ID: 23274669
    [Abstract] [Full Text] [Related]

  • 5. CD8+CD28- T cells: key cytotoxic players impacting disease pathogenesis in chronic HBV infection.
    Nandi M, Pal S, Ghosh S, Chakraborty BC, Dey D, Baidya A, Shil A, Chattopadhyaya S, Banerjee S, Santra A, Chowdhury A, Datta S.
    Clin Sci (Lond); 2019 Sep 13; 133(17):1917-1934. PubMed ID: 31477625
    [Abstract] [Full Text] [Related]

  • 6. Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection.
    Nan XP, Zhang Y, Yu HT, Li Y, Sun RL, Wang JP, Bai XF.
    Viral Immunol; 2010 Feb 13; 23(1):63-70. PubMed ID: 20121403
    [Abstract] [Full Text] [Related]

  • 7. Peripheral blood lymphocyte dynamics and viral kinetics in patients with chronic active hepatitis B virus infection treated by tenofovir.
    Arasli M, Ustundag Y, Delikanli B, Harmandar F, Buyukuysal C.
    Hepatogastroenterology; 2012 May 13; 59(115):851-7. PubMed ID: 22193343
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
    Shao X, Ma J, Jia S, Yang L, Wang W, Jin Z.
    Front Cell Infect Microbiol; 2017 May 13; 7():472. PubMed ID: 29181338
    [Abstract] [Full Text] [Related]

  • 9. Expression of PD-L1 on CD4+CD25+Foxp3+ Regulatory T Cells of Patients with Chronic HBV Infection and Its Correlation with Clinical Parameters.
    Feng C, Cao LJ, Song HF, Xu P, Chen H, Xu JC, Zhu XY, Zhang XG, Wang XF.
    Viral Immunol; 2015 Oct 13; 28(8):418-24. PubMed ID: 26266813
    [Abstract] [Full Text] [Related]

  • 10. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
    Li M, Sun X, Zhou Z, Zhang X, Jin S, Gao Y, Gao Y.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb 13; 32(2):240-4. PubMed ID: 26927386
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z, Zhang JY, Wherry EJ, Jin B, Xu B, Zou ZS, Zhang SY, Li BS, Wang HF, Wu H, Lau GK, Fu YX, Wang FS.
    Gastroenterology; 2008 Jun 13; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [Abstract] [Full Text] [Related]

  • 13. Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14+ Monocytes and CD19+ B Cells with the Progression of Hepatitis B Virus Infection.
    Huang ZY, Xu P, Li JH, Zeng CH, Song HF, Chen H, Zhu YB, Song YY, Lu HL, Shen CP, Zhang XG, Wu MY, Wang XF.
    Viral Immunol; 2017 Apr 13; 30(3):224-231. PubMed ID: 28005469
    [Abstract] [Full Text] [Related]

  • 14. Dissection of a circulating and intrahepatic CD4(+)Foxp3(+) T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states.
    Zhang M, Zhou J, Zhao T, Huang G, Tan Y, Tan S, Fu X, Niu W, Meng G, Chen X, Shang X, Liu D, Ni B, Wang L, Wu Y.
    J Infect Dis; 2012 Apr 01; 205(7):1111-20. PubMed ID: 22357657
    [Abstract] [Full Text] [Related]

  • 15. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection.
    Franzese O, Kennedy PT, Gehring AJ, Gotto J, Williams R, Maini MK, Bertoletti A.
    J Virol; 2005 Mar 01; 79(6):3322-8. PubMed ID: 15731226
    [Abstract] [Full Text] [Related]

  • 16. Influence of Treg cells and HBV genotype on sustained response and drug resistance in the treatment with nucleoside drugs.
    Zhang YR, Li B, Wang CX, Zhou N, Qi W, Li XL, Wu LY, Wei SF, Zhang YD.
    Braz J Med Biol Res; 2017 Mar 02; 50(3):e5796. PubMed ID: 28273209
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The expression of programmed death-1 in circulating CD4+ and CD8+ T cells during hepatitis B virus infection progression and its correlation with clinical baseline characteristics.
    Xu P, Chen YJ, Chen H, Zhu XY, Song HF, Cao LJ, Wang XF.
    Gut Liver; 2014 Mar 02; 8(2):186-95. PubMed ID: 24672661
    [Abstract] [Full Text] [Related]

  • 19. Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B.
    Yang G, Liu A, Xie Q, Guo TB, Wan B, Zhou B, Zhang JZ.
    Int Immunol; 2007 Feb 02; 19(2):133-40. PubMed ID: 17182968
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.